FDA Needs Rule Change For DMAA Crackdown, Suit Says

Law360, New York (November 07, 2013, 2:38 PM ET) -- A weight loss and energy supplement maker hit the U.S. Food and Drug Administration with a lawsuit on Tuesday that accuses it of improperly issuing a detention order on products that contain a controversial stimulant, saying the agency must first go through a formal rule-making process.

Georgia-based Hi-Tech Pharmaceuticals Inc. said in its complaint, filed in D.C. federal court, that the FDA has not engaged in the rule-making process necessary to formally ban the stimulant dimethylamylamine, or DMAA, but still issued an administrative detention order against...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required

Case Information

Case Title

v. HI-TECH PHARMACEUTICALS, INC., A GEORGIA CORPORATION et al

Case Number

1:13-cv-01747

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

November 5, 2013

Sections

Law Firms Mentioned

Companies Mentioned

Government Agencies Mentioned

Related Articles